Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Accounts Payables (2020 - 2025)

Bio Essence has reported Accounts Payables over the past 6 years, most recently at $35854.0 for Q4 2025.

  • Quarterly results put Accounts Payables at $35854.0 for Q4 2025, up 102.13% from a year ago — trailing twelve months through Dec 2025 was $35854.0 (up 102.13% YoY), and the annual figure for FY2025 was $35854.0, up 102.13%.
  • Accounts Payables for Q4 2025 was $35854.0 at Bio Essence, up from $5725.0 in the prior quarter.
  • Over the last five years, Accounts Payables for BIOE hit a ceiling of $466001.0 in Q1 2021 and a floor of $5725.0 in Q3 2025.
  • Median Accounts Payables over the past 5 years was $50300.5 (2022), compared with a mean of $100909.0.
  • Biggest five-year swings in Accounts Payables: skyrocketed 126875.75% in 2021 and later crashed 96.81% in 2025.
  • Bio Essence's Accounts Payables stood at $77109.0 in 2021, then plummeted by 70.13% to $23029.0 in 2022, then tumbled by 45.92% to $12453.0 in 2023, then soared by 42.44% to $17738.0 in 2024, then skyrocketed by 102.13% to $35854.0 in 2025.
  • The last three reported values for Accounts Payables were $35854.0 (Q4 2025), $5725.0 (Q3 2025), and $10692.0 (Q2 2025) per Business Quant data.